Charles Perkins Centre, The University of Sydney, Sydney 2006, Australia.
Sydney Medical School, The University of Sydney, Sydney 2006, Australia.
Nutrients. 2023 Mar 15;15(6):1412. doi: 10.3390/nu15061412.
The gut microbiome has been shown to play a role in the relationship between diet and cardiometabolic health. We sought to examine the degree to which key microbial lignan metabolites are involved in the relationship between diet quality and cardiometabolic health using a multidimensional framework. This analysis was undertaken using cross-sectional data from 4685 US adults (age 43.6 ± 16.5 years; 50.4% female) participating in the National Health and Nutrition Examination Survey for 1999-2010. Dietary data were collected from one to two separate 24-hour dietary recalls and diet quality was characterized using the 2015 Healthy Eating Index. Cardiometabolic health markers included blood lipid profile, glycemic control, adiposity, and blood pressure. Microbial lignan metabolites considered were urinary concentrations of enterolignans, including enterolactone and enterodiol, with higher levels indicating a healthier gut microbial environment. Models were visually examined using a multidimensional approach and statistically analyzed using three-dimensional generalized additive models. There was a significant interactive association between diet quality and microbial lignan metabolites for triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, insulin, oral glucose tolerance, adiposity, systolic blood pressure, and diastolic blood pressure (all < 0.05). Each of these cardiometabolic health markers displayed an association such that optimal cardiometabolic health was only observed in individuals with both high diet quality and elevated urinary enterolignans. When comparing effect sizes on the multidimensional response surfaces and model selection criteria, the strongest support for a potential moderating relationship of the gut microbiome was observed for fasting triglycerides and oral glucose tolerance. In this study, we revealed interactive associations of diet quality and microbial lignan metabolites with cardiometabolic health markers. These findings suggest that the overall association of diet quality on cardiometabolic health may be affected by the gut microbiome.
肠道微生物群已被证明在饮食与心脏代谢健康之间的关系中发挥作用。我们试图使用多维框架来研究关键微生物木质素代谢物在饮食质量与心脏代谢健康之间的关系中所起的作用。这项分析是使用参加 1999-2010 年全国健康与营养调查的 4685 名美国成年人(年龄 43.6±16.5 岁;50.4%为女性)的横断面数据进行的。饮食数据来自一到两次单独的 24 小时饮食回忆,饮食质量用 2015 年健康饮食指数来描述。心脏代谢健康标志物包括血脂谱、血糖控制、肥胖和血压。考虑的微生物木质素代谢物是尿中肠内木质素的浓度,包括肠内酯和肠二醇,浓度越高表明肠道微生物环境越健康。使用多维方法对模型进行直观检查,并使用三维广义加性模型进行统计学分析。饮食质量和微生物木质素代谢物与甘油三酯、低密度脂蛋白胆固醇、高密度脂蛋白胆固醇、胰岛素、口服葡萄糖耐量、肥胖、收缩压和舒张压之间存在显著的交互关联(均<0.05)。这些心脏代谢健康标志物中的每一个都显示出关联,只有在饮食质量高和尿中肠内酯升高的个体中才观察到最佳的心脏代谢健康。在多维响应曲面和模型选择标准上比较效应大小,观察到肠道微生物群对空腹甘油三酯和口服葡萄糖耐量的潜在调节关系的最强支持。在这项研究中,我们揭示了饮食质量和微生物木质素代谢物与心脏代谢健康标志物之间的交互关联。这些发现表明,饮食质量对心脏代谢健康的整体关联可能受到肠道微生物群的影响。